@IsaacKinde

Medical Scientist | Technology Assessment, Exact | Co-founder, Thrive

 San Diego, CA
linkedin.com/in/isaackinde
Joined April 2012
  • Tweets212
  • Following107
  • Followers326
10Media
Cologuard Plus™, our next-generation Cologuard® test, is now FDA approved. With 95% sensitivity for colorectal cancer and 43% sensitivity for advanced precancers, it sets a new performance standard for noninvasive screening. Read the full press release: bit.ly/3ZXEVf4
3
11
4
53
2,361
We’re thrilled to announce that Resolution Bioscience will be joining the Exact Sciences family. This acquisition will further our mission by adding complementary capabilities to our growing portfolio. exactsciences.com/newsroom/p…
1
13
1,133
March 1st marks the start of #ColorectalCancerAwarenessMonth. We look forward to celebrating our patients, sharing some of their stories, and working to raise awareness about colorectal cancer and its impact.

Kicking of Colorectal Cancer Awareness Month

6
19
2,303
In the fight against cancer, the challenges and accomplishments of the Black community are often overlooked. This #BlackHistoryMonth, read about five leaders, including our own @IsaacKinde, who are working to increase equity: exas.co/3YVlWyu @katiecouric
2
10
1,491
We are thrilled to expand Exact Sciences’ presence in San Diego. Our focus for this facility will be to develop next-generation cancer diagnostics to help patients and physicians make better treatment decisions.
2
6
47
This #WorldCancerDay, we’re using this space to share more from these partners and ways to get involved. See more in our Twitter Moment: xitter.cf/i/events/1489621850514…
5
13
We are excited to announce that we are now a part of the @ExactSciences team. We look forward to continuing our work to help make genetic and hereditary cancer testing available to more patients, together. #ChangingLivesTogether ow.ly/rXJI50Hqx1z
2
8
2
24
We’re thrilled to welcome Everett Cunningham to our leadership team as Chief Commercial Officer. Learn more about his impressive background here: exactsciences.com/about/mana…
6
2
28
Katie Couric sits down with CEO Kevin Conroy to discuss our mission to eradicate cancer and how our teams are working to make it possible to detect cancers earlier. ms.spr.ly/6018Xgb4u @katiecouric
2
16
3
37
Honored to be included in this group of healthcare industry leaders
Business Insider
@BusinessInsider16 Aug 2021
Meet Insider's 30 leaders under 40 transforming healthcare businessinsider.com/insiders…

Meet Insider's 30 leaders under 40 transforming healthcare

These are Insider's biggest healthcare stories for August 16.

businessinsider.com
5
Congratulations to Dr. Karlo Perica of @sloan_kettering, recipient of the 2021 SITC-Bristol Myers Squibb (@bmsnews) Postdoctoral Cancer Immunotherapy Translational Fellowship, a 2-year, $200K SITC Fellowship! sitcancer.org/funding/fellow…
1
4
2
50
Isaac Kinde retweeted
4th and 1
@jaesofamous24 Jul 2021
This is the best explanation of the Covid Vaccine I’ve ever heard.
1,094
32,935
5,650
100,208
Semi Trotto, General Manager of Exact Sciences’ Thrive business unit, will be joining @Pharma_Intell panel of biopharma and med tech leaders to discuss leadership in times of uncertainty. Register here to join the webinar: ms.spr.ly/6011VvYTd
1
1
70% of cancers do not currently have a screening test. Sue's story shows why we must deliver new solutions for early detection, and how multi-cancer tests hold promise to lead the way. Read here via @KatieCouric: ms.spr.ly/6019V0Vq5

How a Simple Blood Test May Soon Save Millions of Lives

What if there was a blood test that could tell you if you have cancer before you show any symptoms? Pretty soon, there will be.

katiecouric.com
1
8
1
28
Together with @BloombergDotOrg, we are launching the Vivien Thomas Scholars Initiative, a $150 million effort to increase diversity in #STEM PhD programs, in partnership with HBCUs and MSIs. hub.jhu.edu/2021/05/11/vivie…

Johns Hopkins, Bloomberg Philanthropies announce $150M effort to fuel diversity in STEM fields

The Vivien Thomas Scholars Initiative, announced in partnership with Bloomberg Philanthropies, will create new opportunities and supports for diverse PhD students in Hopkins STEM programs

hub.jhu.edu
2
51
5
129
Dr. Bert Vogelstein’s vision for the future of screening inspires our work every day to advance our multi-cancer earlier detection blood test. ms.spr.ly/6013VUHUB
1
8
1
14
This lung cancer awareness month, our co-founder and head of research & innovation @IsaacKinde emphasizes the importance of screening & the significant impact our blood test had in detecting lung cancer in our DETECT-A study. The future of #earlierdetection is within reach. #LCAM
4
1
10
Isaac Kinde retweeted
MassDevice@MassDevice1 Aug 2020
What in the world will Thrive Earlier Detection do with $257 million? goo.gl/fb/9iMoVx
1
1
4
Isaac Kinde retweeted
JHTV@JHTechVentures29 Jul 2020
"The company will use the $257M to further advance development of CancerSEEK, a liquid biopsy test designed to detect multiple types of cancer at early stages." Great news from @ThriveDetect! #startup #Baltimore (via @BaltBizMorgan) bddy.me/2XaiSRh
3
2
10
We are excited to announce the closing of our $257M Series B financing. Hear from our CFO @isaacro and new board member Eli Casdin about how this will enable the advancement of our blood test, CancerSEEK, to provide better outcomes for patients. thrivedetect.com/press-relea…
1
19
17
73
Load more